Disclosures for "Phase One Study of BT-267: A Potent, Selective, Brain-penetrant, and Oral Small Molecule Inhibitor of LRRK2"
-
Dr. Dam has received personal compensation for serving as an employee of Brenig Therapeutics. Dr. Dam has stock in Brenig Therapeutics.
-
Dr. Dokukina has nothing to disclose.
-
Dr. Remeeva has nothing to disclose.
-
Dr. Kazey has stock in Brenig Therapeutics. Dr. Kazey has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Karapetyan has stock in Brenig Therapeutics.
-
Dr. Pushechnikov has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Brenig Therapeutics. Dr. Pushechnikov has stock in Brenig Therapeutics.
-
Dr. Mathias has nothing to disclose.
-
Mr. Marvasty has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Brenig Therapeutics, Inc.
-
Dr. Savchuk has received personal compensation for serving as an employee of Brenig Therapeutics . Dr. Savchuk has received personal compensation for serving as an employee of Traws Pharma Inc. Dr. Savchuk has received personal compensation for serving as an employee of Lomond Therapeutics Inc. Dr. Savchuk has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Traws Pharma Inc. Dr. Savchuk has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Brenig Therapeutics Inc. Dr. Savchuk has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Lomond Therapeutics Inc . Dr. Savchuk has stock in Brenig Therapeutics Inc. Dr. Savchuk has stock in Lomond Therapeutics Inc. Dr. Savchuk has stock in Clywedog Therapeutics Inc. Dr. Savchuk has received intellectual property interests from a discovery or technology relating to health care.
-
Author has nothing to disclose
-
Dr. Hilt has received personal compensation for serving as an employee of Actinogen Medical. Dr. Hilt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brenig Therapeutics.